Almost 25% of COVID-19 Patients Develop Long-Lasting Symptoms, According to a New Report
A year and a half into the pandemic, the condition known as Long COVID continues to stump doctors. A significant number of patients develop long-term symptoms after catching COVID-19, but it hasn’t been clear why that happens, who is likely to get sick or even how many people continue to suffer. A large new study may help form some answers to those questions. In line with prior estimates, it finds that almost a quarter of people infected with the virus develop at least one lingering health problem, and that most Long COVID symptoms are more commonly reported by women than men. [time-brightcove not-tgx=”true&rdq...
Source: TIME: Health - June 15, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Chronic Headache Pain Linked to Suicide Attempts Chronic Headache Pain Linked to Suicide Attempts
US veterans with chronic headache pain have a higher increased risk of attempting suicide than their counterparts with chronic neck or back pain, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 15, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Doctors May Be Overprescribing Opioids After Surgeries
Title: Doctors May Be Overprescribing Opioids After SurgeriesCategory: Health NewsCreated: 6/14/2021 12:00:00 AMLast Editorial Review: 6/14/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - June 14, 2021 Category: Anesthesiology Source Type: news

Dacrocystitis in a Teenager?
Discussion Tears are produced in the lacrimal gland which resides in the upper outer quadrant of the eye. The tears flow across the eye medially and are collected in the superior and inferior puncta which drain into their respective canaliculi, and these drain into a common canaliculus. Tears then pass through the valve of Rosenmuler into the lacrimal sac where they are collected. Tears then pass through the nasolacrimal duct, through the distal valve of Hasner and into the nasal cavity. Vascular connections are extensive in this anatomic area and veins do not have valves. Therefore infections can spread easily through dir...
Source: PediatricEducation.org - June 14, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

New Phase 3 Study Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVICA® plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study demonstrated superior progression-free survival (PFS) of a once-daily, all-oral, fixed-duration regimen of I+V versus Clb+O as first-line treatment of CLL; the study also showed improved duratio...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Sleep and injury risk - Huang K, Ihm J.
Sleep has been found to have wide-ranging effects on sports performance and overall well-being. Recent research has found evidence relating chronic suboptimal sleep with the risk of musculoskeletal pain and sports injury. The amount of sleep that consisten... (Source: SafetyLit)
Source: SafetyLit - June 11, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Gene Editing Technique Corrects Sickle Cell Disease in Mice
Title: Gene Editing Technique Corrects Sickle Cell Disease in MiceCategory: Health NewsCreated: 6/10/2021 12:00:00 AMLast Editorial Review: 6/10/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - June 10, 2021 Category: Anesthesiology Source Type: news

Some Patients Are Reporting Long COVID Recoveries —But Experts Still Don’t Fully Understand Why
A few months ago, Lana Lynch had resigned herself to never getting better. Months after testing positive for COVID-19, she still felt fatigued, still got daily headaches, still had to carefully regulate how much she exerted herself each day. She was coming to terms with her new normal—until she didn’t have to. After receiving her second dose of the Pfizer-BioNTech COVID-19 vaccine in May, Lynch, a 32-year-old from Texas, noticed that she wasn’t quite so tired anymore. She could get through a yoga class without hitting a wall. “I felt like I had some energy,” she says, “but I didn’t...
Source: TIME: Health - June 9, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Chronic pain in adults 2017
This report explores the responses to questions on chronic pain in the 2017 health survey for England. (Source: NHS Networks)
Source: NHS Networks - June 9, 2021 Category: UK Health Source Type: news

Senior care coordination startup DUOS emerges from stealth, the Arthritis Foundation rolls out chronic pain app and more digital health news briefs
Also: CarePort launches a new system to rate skilled nursing facilities, and Fertility Focus  rolls out a wearable that helps track ovulation.  (Source: mobihealthnews)
Source: mobihealthnews - June 8, 2021 Category: Information Technology Source Type: news

The Big Number: 50.2 million people live with chronic pain in the U.S.
The most common types are back pain (reported by about 41 percent) and hip, knee or foot pain (about 44 percent), researchers say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 5, 2021 Category: Consumer Health News Authors: Linda Searing Source Type: news

375,000 Britons say they are still suffering from Long Covid, official report finds
An Office for National Statistics survey also found a million Britons were experiencing symptoms including chronic fatigue and muscle pain at least four weeks after infection. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2021 Category: Consumer Health News Source Type: news

Cells to Society: Adaptation and Advancement
.ReadMsgBody{ width:100%; background-color:#ffffff; } .ExternalClass{ width:100%; background-color:#ffffff; } .ExternalClass,.ExternalClass p,.ExternalClass span,.ExternalClass font,.ExternalClass td,.ExternalClass div{ line-height:100%; } html{ width:100%; } body{ -webkit-text-size-adjust:none; -ms-text-size-adjust:none; margin:0; padding:0; } table{ border-spacing:0; border-collapse:collapse; } img{ display:block !important; } table td{ border-collapse:collapse; } .yshortcuts a{ border-bottom:none !important; } a{ color:#E03C31; ...
Source: Johns Hopkins University and Health Systems Archive - June 4, 2021 Category: Nursing Source Type: news

What Is a 10 on the Pain Scale?
Title: What Is a 10 on the Pain Scale?Category: Health and LivingCreated: 6/3/2021 12:00:00 AMLast Editorial Review: 6/3/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - June 3, 2021 Category: Anesthesiology Source Type: news

Genetic base editing treats sickle cell disease in mice
(Broad Institute of MIT and Harvard) Sickle cell disease leads to chronic pain, organ failure, and early death in patients worldwide. A team led by Broad Institute of MIT and Harvard and St. Jude Children's Research Hospital has demonstrated a gene editing approach that efficiently corrects the mutation underlying SCD in patient blood stem cells and in mice. This treatment rescued disease symptoms in animal models, enabling long-lasting production of healthy blood cells, and could inspire a therapeutic strategy for SCD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2021 Category: International Medicine & Public Health Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Canadian prescription opioids users experience gaps in access to care
(PLOS) Stigma and high care needs can present barriers to the provision of high-quality primary care for people with opioid use disorder (OUD) and those prescribed opioids for chronic pain. A study by Tara Gomes at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Canada and colleagues suggests that people treated for an opioid use disorder were less likely to find a new primary care provider (PCP) within one year of termination of enrolment with the previous physician. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 1, 2021 Category: International Medicine & Public Health Source Type: news

‘On That Edge of Fear’: One Woman’s Struggle With Sickle Cell Pain
Cures for a disease that mostly afflicts Black people seem near, but may come too late for Lisa Craig, who lives with an agony like knives stabbing her bones. (Source: NYT Health)
Source: NYT Health - May 30, 2021 Category: Consumer Health News Authors: John Eligon and William DeShazer Tags: Sickle Cell Anemia Pain-Relieving Drugs Chronic Condition (Health) Addiction (Psychology) Opioids and Opiates Race and Ethnicity Doctors Blood Black People Vanderbilt University Medical Center Source Type: news

Journal Highlights From the June/July Issue of JAMDA
Chronic pain can decrease quality of life, impair daily functioning, and worsen symptoms of depression and anxiety, and concerns about undertreating or overtreating pain make this both a clinical and public health challenge, researchers said. (Source: Caring for the Ages)
Source: Caring for the Ages - May 29, 2021 Category: Health Management Tags: Journal Highlights Source Type: news

Naltrexone as an Alternative in Treating Chronic Pain
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - May 27, 2021 Category: Orthopaedics Tags: Trends and Innovations Source Type: news

Trigeminal Neuralgia (Facial Pain)
 Markers for Pain ResearchTrigeminal Neuralgia is a progress chronic condition. Dysfunctional trigeminal signaling can lead to intense, searing facial pain. It is caused by pressure on the trigeminal nerve.The root causes of the condition are not well understood. Ourpain research markers have been widely used and frequently published through the years and have been important contributors to our growth, Here's a recent pub referencing use of one ourP2X3 Antibodies-Momoko Koizumi, Sayaka Asano, Akihiko Furukawa, Yoshinori Hayashi, Suzuro Hitomi, Ikuko Shibuta, Katsuhiko Hayashi, Fusao Kato, Koichi Iwata, and Masamichi S...
Source: Neuromics - May 27, 2021 Category: Neuroscience Tags: Craniofacial pain P2X3 Antibody P2X3 Receptor Antibody Trigeminal Neurons Source Type: news

Long-Term ERLEADA ® (apalutamide) Patient-Reported Outcomes Data in Metastatic Castration-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients
May 26, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced patient-reported outcomes (PRO) data from the pre-specified final analysis of the Phase 3 TITAN study in patients with metastatic castration-sensitive prostate cancer (mCSPC). The TITAN study previously demonstrated statistically significant improvement in overall survival (OS) after a median follow-up of 44 months in patients receiving ERLEADA® plus androgen deprivation therapy (ADT).1 The new PRO data showed that the addition of ERLEADA® to ADT maintained patients’ health-related quality of lif...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Can Flotation Tanks Ease Chronic Pain?
WEDNESDAY, May 26, 2021 -- As a means of providing long-term relief from chronic pain, flotation tanks simply don't hold water, new research reveals. Nearly 100 people plagued by longstanding pain underwent " flotation restricted environmental... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2021 Category: General Medicine Source Type: news

Shoulder Pain Can Plague Wheelchair Users, But Their Own Fat Cells Could Be Cure
WEDNESDAY, May 26, 2021 -- People with spinal cord injuries can overwork their shoulders as they move about in a wheelchair, and that often leads to chronic shoulder pain. However, a small study suggests that an injection of the patient's own fat... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2021 Category: General Medicine Source Type: news

Shoulder Pain Can Plague Wheelchair Users, But Their Own Fat Cells Could Be Cure
Title: Shoulder Pain Can Plague Wheelchair Users, But Their Own Fat Cells Could Be CureCategory: Health NewsCreated: 5/26/2021 12:00:00 AMLast Editorial Review: 5/26/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - May 26, 2021 Category: Anesthesiology Source Type: news

Can Flotation Tanks Ease Chronic Pain?
Title: Can Flotation Tanks Ease Chronic Pain?Category: Health NewsCreated: 5/26/2021 12:00:00 AMLast Editorial Review: 5/26/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - May 26, 2021 Category: Anesthesiology Source Type: news

Validation of the Danish International Trauma Questionnaire for posttraumatic stress disorder in chronic pain patients using clinician-rated diagnostic interviews - Hansen M, V ægter HB, Cloitre M, Andersen TE.
BACKGROUND: The estimated prevalence rate of comorbid posttraumatic stress disorder (PTSD) is high in trauma-exposed chronic pain patients. At the same time, self-report measures of PTSD tend to be over-inclusive within this specific population due to the ... (Source: SafetyLit)
Source: SafetyLit - May 26, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Are the Side Effects of Ibuprofen?
Title: What Are the Side Effects of Ibuprofen?Category: Diseases and ConditionsCreated: 5/20/2021 12:00:00 AMLast Editorial Review: 5/20/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - May 20, 2021 Category: Anesthesiology Source Type: news

IMBRUVICA ® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukemia Demonstrates High Rates of Disease Control
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the fixed-duration cohort of the investigational Phase 2 CAPTIVATE study, showing that 95 percent of patients treated with combined IMBRUVICA® plus venetoclax were alive and progression-free at two years.[1] Deep remissions were seen across all subgroups, including patients with high-risk chronic lymphocytic leukemia (CLL).1 In addition, long-term data from the RESONATE-2 (PCYC-1115/1116) study will be presented, providing the longest follow-up Phase 3 data for any BTK inhibitor to date. Thes...
Source: Johnson and Johnson - May 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Characterizing Chronic Pain Phenotypes in Multiple Sclerosis Characterizing Chronic Pain Phenotypes in Multiple Sclerosis
This study aimed to characterize and compare pain phenotypes in MS in terms of pain type and intensity, chronic overlapping pain conditions, and medication use and associated relief.Pain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Why Do Patients With Chronic Hepatitis C Drink Alcohol? Why Do Patients With Chronic Hepatitis C Drink Alcohol?
This study examines how sociodemographic factors, chronic pain, and depression relate to the motivations of individuals with chronic HCV to consume alcohol.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

How Dangerous Is Brain Surgery?
Title: How Dangerous Is Brain Surgery?Category: Diseases and ConditionsCreated: 5/17/2021 12:00:00 AMLast Editorial Review: 5/17/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - May 17, 2021 Category: Anesthesiology Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Why men and women feel pain differently
Not only do women have it worse, a physician says, they are much more likely to experience chronic pain than men. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 15, 2021 Category: Consumer Health News Authors: Haider J. Warraich Source Type: news

Peptide could allow medical marijuana to relieve pain without side effects
(American Chemical Society) Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions. Now, researchers reporting in ACS'Journal of Medicinal Chemistry have developed a peptide that, in mice, allowedΔ9-tetrahydrocannabinol (THC), the main component ofCannabis sativa, to fight pain without the side effects. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 12, 2021 Category: Biology Source Type: news

Interdisciplinary consults can help primary care docs treat patients with chronic pain
(American Academy of Family Physicians) Between 11% to 40% of adults in the United States experience chronic pain, and primary care physicians may feel ill-equipped to effectively and safely care for patients with chronic pain, addiction or both. Researchers from Tufts University conducted a study to evaluate the effectiveness of an interdisciplinary consultation service that supports primary care physicians who care for patients experiencing chronic pain and addiction. The goal was to identify new and effective strategies that clinics can use to support PCPs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2021 Category: International Medicine & Public Health Source Type: news

Americans are increasingly experiencing chronic pain
This study comprehensively documents rising levels of chronic pain among Americans aged 25-84 to show that pain prevalence -- already high at baseline -- increased substantially from 2002-18, with increases evident in all leading pain sits (joint, back, neck, jaw and migraine). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2021 Category: International Medicine & Public Health Source Type: news

Controlling cholesterol in microglia alleviates chronic pain, opioid-free
(University of California - San Diego) Chemotherapy can induce a painful peripheral neuropathy (CIPN), a chronic condition and common adverse effect for cancer patients undergoing treatment. Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, have used a mouse model to demonstrate the pivotal role of cholesterol in CIPN, and proposed a novel therapeutic approach to reverse it. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 10, 2021 Category: Cancer & Oncology Source Type: news

Chronic pain can be burdensome. Isolation during the pandemic can make it worse.
The coronavirus disrupted medical appointments, physical therapy sessions and social activities. It also sparked depression and anxiety, which exacerbated the pain. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 9, 2021 Category: Consumer Health News Authors: Marlene Cimons Source Type: news

Ketamine Wellness Centers, largest ketamine infusion group in U.S.,...
Major advance in treatment of difficult depression, anxiety, and chronic pain now accessible to more Nevadans(PRWeb May 08, 2021)Read the full story at https://www.prweb.com/releases/ketamine_wellness_centers_largest_ketamine_infusion_group_in_u_s_opens_in_las_vegas/prweb17921511.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 8, 2021 Category: Pharmaceuticals Source Type: news

Kessler Foundation studies new option for treating neck pain in active-duty military
(Kessler Foundation) The study targets neck pain, which is common among active-duty servicemen and women. mechanical factors are usually a factor, including forward head posture, which places excess strain on the soft tissues of the cervical spine and causes loss of the normal lordotic curve. If not treated properly, this can lead to degenerative changes, chronic pain, and declines in function and quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 5, 2021 Category: International Medicine & Public Health Source Type: news

Water ski injuries and chronic pain in collegiate athletes - Jung HC, Straltsova H, Woodgate MA, Kim KM, Lee JM, Lee JH, Gann JJ.
This study examined the rate of injuries and chronic pain in collegiate water-ski athletes as a preliminary study. We also compared the mechanics and cause of injuries by the level of water-skiing experiences. A total number of 96 collegiate water-ski athl... (Source: SafetyLit)
Source: SafetyLit - May 3, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Addiction Medication Promising for Chronic, Refractory Pain Addiction Medication Promising for Chronic, Refractory Pain
Used primarily for addiction, low-dose naltrexone may also turn out to be a useful treatment for refractory chronic pain, early research suggests.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 30, 2021 Category: Internal Medicine Tags: Family Medicine/Primary Care News Source Type: news

Your Blood Type Might Raise Odds for Certain Health Conditions
Title: Your Blood Type Might Raise Odds for Certain Health ConditionsCategory: Health NewsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - April 30, 2021 Category: Anesthesiology Source Type: news

How much does it itch?
(Northwestern University) Itch can be as debilitating as chronic pain. But it's a hard symptom to measure -- particularly for the 10 million U.S. children with atopic dermatitis, also known as eczema. But now there is a soft, wearable sensor that quantifies itch by measuring scratching when placed on the hand. It allows parents and doctors to track how well itch is being controlled in patients, monitor treatment response and early signs of worsening disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2021 Category: Cancer & Oncology Source Type: news

Ankle Pain (Tendonitis)
Title: Ankle Pain (Tendonitis)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 4/29/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - April 29, 2021 Category: Anesthesiology Source Type: news

CBD: Pain Reliever or Placebo?
Title: CBD: Pain Reliever or Placebo?Category: Health NewsCreated: 4/29/2021 12:00:00 AMLast Editorial Review: 4/29/2021 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - April 29, 2021 Category: Anesthesiology Source Type: news